| Population level impact of the NHS Diabetes Prevention Programme on incidence of type 2 diabetes in England: an observational study E McManus, R Meacock, B Parkinson, M Sutton The Lancet Regional Health–Europe 19, 2022 | 32 | 2022 |
| Incidence and sociodemographic characteristics of eczema diagnosis in children: a cohort study L Ban, SM Langan, K Abuabara, KS Thomas, AA Sultan, T Sach, ... Journal of Allergy and Clinical Immunology 141 (5), 1927-1929. e8, 2018 | 24 | 2018 |
| Barriers and facilitators to model replication within health economics E McManus, D Turner, E Gray, H Khawar, T Okoli, T Sach Value in Health 22 (9), 1018-1025, 2019 | 13 | 2019 |
| Understanding economic evidence for the prevention and treatment of atopic eczema TH Sach, E Mcmanus, NJ Levell British Journal of Dermatology 181 (4), 707-716, 2019 | 12 | 2019 |
| Referral to the NHS Diabetes Prevention Programme and conversion from nondiabetic hyperglycaemia to type 2 diabetes mellitus in England: A matched cohort analysis R Ravindrarajah, M Sutton, D Reeves, S Cotterill, E Mcmanus, R Meacock, ... PLoS Medicine 20 (2), e1004177, 2023 | 11 | 2023 |
| The effects of structure, process and outcome incentives on primary care referrals to a national prevention programme E McManus, J Elliott, R Meacock, P Wilson, J Gellatly, M Sutton Health Economics 30 (6), 1393-1416, 2021 | 11 | 2021 |
| Sociodemographic disparities in non‐diabetic hyperglycaemia and the transition to type 2 diabetes: evidence from the English longitudinal study of ageing G Chatzi, T Mason, T Chandola, W Whittaker, E Howarth, S Cotterill, ... Diabetic Medicine 37 (9), 1536-1544, 2020 | 11 | 2020 |
| Can you repeat that? Exploring the definition of a successful model replication in health economics E McManus, D Turner, T Sach Pharmacoeconomics 37 (11), 1371-1381, 2019 | 11 | 2019 |
| The use of decision–analytic models in atopic eczema: a systematic review and critical appraisal E McManus, T Sach, N Levell Pharmacoeconomics 36, 51-66, 2018 | 11 | 2018 |
| Economic evidence for the prevention and treatment of atopic eczema: a protocol for a systematic review TH Sach, E McManus, C Mcmonagle, N Levell Systematic Reviews 5, 1-11, 2016 | 10 | 2016 |
| Are vitiligo treatments cost‐effective? A systematic review E McManus, T Sach, NJ Levell British Journal of Dermatology 178 (1), e57-e58, 2018 | 9 | 2018 |
| A systematic review of model-based economic evaluations of treatments for venous leg ulcers A Layer, E McManus, NJ Levell PharmacoEconomics-Open 4, 211-222, 2020 | 8 | 2020 |
| An introduction to the methods of decision‐analytic modelling used in economic evaluations for Dermatologists E Mcmanus, TH Sach, NJ Levell Journal of the European Academy of Dermatology and Venereology 33 (10), 1829 …, 2019 | 7 | 2019 |
| Does recruiting patients to diabetes prevention programmes via primary care reinforce existing inequalities in care provision between general practices? A retrospective … B Parkinson, E McManus, M Sutton, R Meacock BMJ Quality & Safety 32 (5), 274-285, 2023 | 6 | 2023 |
| Evaluating the short-term costs and benefits of a nationwide diabetes prevention programme in England: retrospective observational study E McManus, R Meacock, B Parkinson, M Sutton Applied health economics and health policy 21 (6), 891-903, 2023 | 3 | 2023 |
| Comment on “replicating health economic models: firm foundations or a house of cards?” E McManus, T Sach PharmacoEconomics 35 (11), 1187-1188, 2017 | 3 | 2017 |
| The effectiveness of the NHS Diabetes Prevention Programme at reducing type 2 diabetes incidence amongst people with non-diabetic hyperglycaemia B Parkinson, E McManus, R Meacock, M Sutton DIABETIC MEDICINE 39, 2022 | 2 | 2022 |
| The comparative performance of the CHU-9D and Adqol amongst children aged 5 years or more with eczema: Evidence from the Clothes Randomised Controlled Trial TH Sach, E McManus, K Thomas, A Montgomery, E Harrison, H Williams, ... Value in Health 20 (9), A406, 2017 | 1 | 2017 |
| Exploring the use of value of information methods to prioritise research to address the treatment uncertainties identified by the James Lind Alliance priority setting partnerships T Sach, E McManus Value in Health 18 (7), A730, 2015 | 1 | 2015 |
| Evaluating the Long-Term Cost-Effectiveness of the English NHS Diabetes Prevention Programme using a Markov Model E McManus PharmacoEconomics-Open, 1-15, 2024 | | 2024 |
